Molecular Breast Imaging in Clinical Practice.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32551908.
- Also identified by DOI 10.2214/AJR.19.22622.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>OBJECTIVE.</b> The purpose of this article is to review clinical uses and image interpretation of molecular breast imaging (MBI) and clarify radiation risks. <b>CONCLUSION.</b> MBI detects additional cancers compared with conventional imaging in women with dense breasts and those with elevated risk of breast cancer. Its role as an imaging biomarker of cancer risk and in assessing neoadjuvant chemotherapy response is growing. Radiation risk is minimal; benefit-to-risk ratio is similar to that of mammography. MBI is low cost, well tolerated, and easily adapted into clinical practice.
Medical subject headings
- Breast Density
- Breast Neoplasms
- Molecular Imaging